TARALLO, Roberta
 Distribuzione geografica
Continente #
AS - Asia 6.677
NA - Nord America 3.877
EU - Europa 1.382
SA - Sud America 160
AF - Africa 22
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.127
Nazione #
HK - Hong Kong 5.642
US - Stati Uniti d'America 3.825
IT - Italia 452
SG - Singapore 387
CN - Cina 359
RU - Federazione Russa 242
DE - Germania 175
BR - Brasile 147
UA - Ucraina 139
IE - Irlanda 87
KR - Corea 68
SE - Svezia 67
TR - Turchia 66
FI - Finlandia 60
VN - Vietnam 51
GB - Regno Unito 44
CA - Canada 36
IN - India 35
NL - Olanda 26
JP - Giappone 23
PL - Polonia 17
AT - Austria 14
ES - Italia 13
MX - Messico 13
CZ - Repubblica Ceca 11
BD - Bangladesh 10
ZA - Sudafrica 8
AR - Argentina 6
FR - Francia 6
IQ - Iraq 6
CH - Svizzera 5
SA - Arabia Saudita 5
ID - Indonesia 4
PK - Pakistan 4
PY - Paraguay 4
EU - Europa 3
HR - Croazia 3
LT - Lituania 3
MA - Marocco 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BE - Belgio 2
DZ - Algeria 2
EG - Egitto 2
HU - Ungheria 2
IL - Israele 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
AD - Andorra 1
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CO - Colombia 1
CV - Capo Verde 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
GM - Gambi 1
GR - Grecia 1
LB - Libano 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NR - Nauru 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
SD - Sudan 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.127
Città #
Hong Kong 5.635
Ann Arbor 715
Dallas 511
Chandler 407
Woodbridge 235
Princeton 225
Jacksonville 189
Ashburn 187
Wilmington 179
Singapore 156
Houston 154
Salerno 128
Dublin 83
Beijing 78
Munich 76
Izmir 54
Naples 54
Andover 50
Nanjing 41
Boardman 37
Dearborn 36
Los Angeles 36
Moscow 35
Dong Ket 32
Turku 29
New York 28
Fairfield 27
Pellezzano 27
The Dalles 26
Santa Clara 23
Shenyang 23
Tokyo 20
Columbus 18
Hebei 18
Washington 17
Brooklyn 16
Nuremberg 16
Warsaw 15
Atlanta 13
Changsha 13
Fisciano 13
Mercato San Severino 13
Nürnberg 13
São Paulo 13
Montreal 12
Seattle 12
Brno 11
Chicago 11
San Francisco 11
Amsterdam 10
Boston 10
Guangzhou 10
London 10
Milan 10
Phoenix 10
Stockholm 10
Denver 9
Düsseldorf 9
Pune 9
Tianjin 9
Vienna 9
Cambridge 8
Nanchang 8
Norwalk 8
Chennai 7
Hanoi 7
Jinan 7
Redwood City 7
Renton 7
Seoul 7
Zhengzhou 7
Jiaxing 6
Johannesburg 6
Manchester 6
Orem 6
Pisa 6
Poplar 6
Rome 6
San Jose 6
Toronto 6
Ankara 5
Calgary 5
Council Bluffs 5
Esslingen am Neckar 5
Falls Church 5
Ho Chi Minh City 5
Mele 5
Mexico City 5
Rio de Janeiro 5
San Giorgio A Cremano 5
Arzano 4
Bari 4
Charlotte 4
Edinburgh 4
Frankfurt am Main 4
Jakarta 4
Jeddah 4
Napoli 4
Pittsburgh 4
Sarno 4
Totale 10.103
Nome #
Small non-coding RNA deregulation in endometrial carcinogenesis 1.085
The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei 690
Molecular mechanisms of selective estrogen receptor modulator activity in human breast cancer cells: Identification of novel nuclear cofactors of antiestrogen-ERα complexes by interaction proteomics. 522
Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer 467
WIND (Workflow for pIRNAs aNd beyonD): a strategy for in-depth analysis of small RNA-seq data 460
Global View of Candidate Therapeutic Target Genes in Hormone-Responsive Breast Cancer 454
Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis 442
Estrogen Receptor α Controls a Gene Network in Luminal-like Breast Cancer Cells Comprising Multiple Transcription Factors and microRNAs. 430
Expression and Function of Phosphodiesterase Type 5 in Human Breast Cancer Cell Lines and Tissues: Implications for Targeted Therapy 417
Host nasopharyngeal transcriptome dataset of a SARS-CoV-2 positive Italian cohort 415
Small non-coding RNA transcriptomic profiling in adult and fetal human brain 309
Small Non-Coding RNA Profiling Identifies miR-181a-5p as a Mediator of Estrogen Receptor Beta-Induced Inhibition of Cholesterol Biosynthesis in Triple-Negative Breast Cancer 202
Essential gene screening identifies the bromodomain-containing protein BRPF1 as a new actionable target for endocrine therapy-resistant breast cancers 198
Splicing of platelet resident pre-mRNAs upon activation by physiological stimuli results in functionally relevant proteome modifications. 194
Identification of Genes Selectively Regulated in Human Hepatoma Cells by Treatment With Dyslipidemic Sera and PUFAs 183
iSmaRT: a toolkit for a comprehensive analysis of small RNA-Seq data 173
Identification of cytoplasmic proteins interacting with unliganded estrogen receptor α and β in human breast cancer cells 172
The nuclear receptor ERβ engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading 171
Activation of Farnesoid X Receptor Impairs The Tumor-Promoting Function of Breast Cancer-Associated Fibroblasts 162
Higher integrin alpha 3 beta1 expression in papillary thyroid cancer is associated with worst outcome 159
Effects of Oestrogen on MicroRNA Expression in Hormone-Responsive Breast Cancer Cells 146
Activating stimuli induce platelet microRNA modulation and proteome reorganisation 144
A large set of estrogen receptor beta-interacting proteins identified by tandem affinity purification in hormone-responsive human breast cancer cells nuclei. 142
Global Analysis of Estrogen Receptor Beta Binding to Breast Cancer Cell Genome Reveals Extensive Interplay with Estrogen Receptor Alpha for Target Gene Regulation. 136
Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies 134
Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer. 131
Phenytoin neurotoxicity in a child carrying new STXBP1 and CYP2C9 gene mutations. 130
Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells 128
Comparative analysis of nuclear estrogen receptor alpha and beta interactomes in breast cancer cells. 127
Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma 126
Carcinogenic risk and Bisphenol A exposure: A focus on molecular aspects in endoderm derived glands 120
New Insights on Estrogen Receptor Actions in Hormone-responsive Breast Cancer Cells by Interaction Proteomics 119
Post-transcriptional regulation of human breast cancer cell proteome by unliganded Estrogen Receptor beta via microRNAs. 111
Timed regulation of P-Element-Induced Wimpy Testis-interacting RNA expression during rat liver regeneration. 110
Identification of a hormone-regulated dynamic actin network associated with estrogen receptor alpha in human breast cancer cell nuclei. 106
Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy 105
Identification of proteins associated with ligand-activated estrogen receptor alpha in human breast cancer cell nuclei by tandem affinity purification and nanoLC-MS/MS. 104
Identification of long non‑coding RNA expression patterns useful for molecular‑based classification of type I endometrial cancers 104
Histone macroH2A1.2 promotes metabolic health and leanness by inhibiting adipogenesis 103
Quantitative mapping of RNA-mediated nuclear Estrogen Receptor β interactome in human breast cancer cells 103
iMir: an integrated pipeline for high-throughput analysis of small non-coding RNA data obtained by smallRNA-Seq. 100
Relations of gut liver axis components and gut microbiota in obese children with fatty liver: A pilot study 100
Interaction Proteomics Identifies ERbeta Association with Chromatin Repressive Complexes to Inhibit Cholesterol Biosynthesis and Exert An Oncosuppressive Role in Triple-negative Breast Cancer 97
The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting 96
PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach 95
RNA sequencing identifies specific PIWI-interacting small non-coding RNA expression patterns in breast cancer. 94
The "busy life" of unliganded estrogen receptors 94
Inhibition of histone methyltransferase DOT1L silences ER gene and blocks proliferation of antiestrogen-resistant breast cancer cells 89
Molecular and Functional Characterization of the Somatic PIWIL1/piRNA Pathway in Colorectal Cancer Cells 87
Histone Methyltransferase DOT1L as a Promising Epigenetic Target for Treatment of Solid Tumors 84
Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer 81
HOME-BIO (sHOtgun MEtagenomic analysis of BIOlogical entities): a specific and comprehensive pipeline for metagenomic shotgun sequencing data analysis 81
An overview of candidate therapeutic target genes in ovarian cancer 79
Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes 78
Lack of pathogenic mutations in six patients with MMPSI. 74
Metabolic Regulation of Epigenetic Modifications and Cell Differentiation in Cancer 73
Colchicine reduces platelet aggregation by modulating cytoskeleton rearrangement via inhibition of cofilin and LIM domain kinase 1 72
Identification of Antiestrogen-Bound Estrogen Receptor α Interactomes in Hormone-Responsive Human Breast Cancer Cell Nuclei 71
Pesticide toxicogenomics across scales: In vitro transcriptome predicts mechanisms and outcomes of exposure in vivo 70
Quantitative expression profiling of highly degraded RNA from formalin-fixed, paraffin-embedded breast tumor biopsies by oligonucleotide microarrays. 67
Integrated Analysis of the Estrogen-Responsive Transcriptome and Estrogen Receptor (ER)-α Binding to Chromatin in Breast Cancer Cells. 66
Leptin Signaling Contributes to Aromatase Inhibitor Resistant Breast Cancer Cell Growth and Activation of Macrophages 65
Whole-Exome Sequencing Revealed New Candidate Genes for Human Dilated Cardiomyopathy 64
Regulation of metabolic reprogramming by long non-coding rnas in cancer 61
MicroRNA Regulation of the Hyper-Proliferative Phenotype of Vascular Smooth Muscle Cells in Diabetes Mellitus 60
Targeted molecular profiling of epithelial ovarian cancer from Italian BRCA wild-type patients with a BRCA and PARP pathways gene panel 59
Transcriptomic profiling of calcified aortic valves in clonal hematopoiesis of indeterminate potential carriers 59
Analisi dei miRNA come possibili biomarcatori per la diagnosi dei tumori neuroendocrini 58
The Histone Methyltransferase DOT1L Is a Functional Component of Estrogen Receptor Alpha Signaling in Ovarian Cancer Cells 58
Functional Relationships between Long Non-Coding RNAs and Estrogen Receptor Alpha: A New Frontier in Hormone-Responsive Breast Cancer Management 51
Integrated Analysis of Estrogen -Responsive Transcriptome and Estrogen Receptor alpha Binding to Chromatin in Breast Cancer Cells. 50
Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer 49
Uncoupling effects of estrogen receptor α on LKB1/AMPK interaction upon adiponectin exposure in breast cancer 48
LncRNA PVT1 links estrogen receptor alpha and the polycomb repressive complex 2 in suppression of pro-apoptotic genes in hormone-responsive breast cancer 44
Caratterizzazione genomica e trascrittomica di tumori neuroendocrini gastro-enteropancreatici 44
Genome-wide DNA methylation changes upon DOT1L inhibition in hormone-responsive breast cancer cells 41
BRPF1 inhibition reduces migration and invasion of metastatic ovarian cancer cells, representing a potential therapeutic target 41
Integration of miRNA:mRNA Co-Expression Revealed Crucial Mechanisms Modulated in Immunogenic Cancer Cell Death 34
BRPF1 in cancer epigenetics: a key regulator of histone acetylation and a promising therapeutic target 21
Totale 12.389
Categoria #
all - tutte 34.263
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.263


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021288 0 0 0 0 37 20 38 8 78 9 49 49
2021/2022421 14 0 2 1 34 7 3 15 51 49 65 180
2022/2023899 69 100 40 131 85 150 12 103 128 8 51 22
2023/2024410 36 41 32 17 31 70 55 18 4 14 16 76
2024/20251.215 20 10 6 35 84 132 233 80 217 70 188 140
2025/20266.920 1.043 2.674 2.797 315 91 0 0 0 0 0 0 0
Totale 12.389